Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TG THERAPEUTICS, INC. | 300,000 | reported | 03 Mar 2010 | tx 4+430,633 |
| BioXcel Therapeutics, Inc. | 26,300 | reported | 20 May 2026 | tx 82+619,424−73,108 |
| ELECTRO OPTICAL SCIENCES INC /NY | 25,000 | reported | 05 Aug 2013 | tx 8+303,304 |
| ATOSSA THERAPEUTICS, INC. | 10,000 | reported | 12 May 2026 | tx 16+835,227−22,728 |
| Cactus Ventures, Inc. | 0 | reported | 31 Mar 2025 | tx 22+735,601−184,984 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 17,500 | — | 10b5-1 |
| 20 May 2026 | SALE | BioXcel Therapeutics, Inc. | 6,845 | 1.08 USD | 10b5-1 |
| 04 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 17,500 | 0.00 USD | 10b5-1deriv |
| 12 May 2026 | GRANT_AWARD | ATOSSA THERAPEUTICS, INC. | 10,000 | 0.00 USD | |
| 01 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 9,000 | — | |
| 01 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — | |
| 14 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | 0.00 USD | deriv |
| 01 Jan 2026 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 70,000 | 0.00 USD | deriv |
| 14 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — | |
| 15 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | 0.00 USD | deriv |
| 15 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — | |
| 15 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | 0.00 USD | deriv |
| 14 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | 0.00 USD | deriv |
| 01 Aug 2025 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 22 Jul 2025 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 4,375 | — | |
| 22 Jul 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 625 | — | |
| 22 Jul 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 625 | 0.00 USD | deriv |
| 15 Jun 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Jun 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — |
3 purchases reported after at least 12 months of silence — most recent on 29 Nov 2018.